Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 8526438, 16 pages
https://doi.org/10.1155/2017/8526438
Review Article

Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke

1Department of Chinese Medicine, College of Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Kaohsiung, Taiwan
2Kaohsiung Medical University College of Medicine, Kaohsiung, Taiwan
3Fooyin University College of Nursing, Kaohsiung, Taiwan
4School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung, Taiwan

Correspondence should be addressed to Yu-Chiang Hung; moc.liamg@gnaihcuygnuh

Received 31 July 2017; Revised 16 October 2017; Accepted 18 October 2017; Published 26 November 2017

Academic Editor: Anna M. Giudetti

Copyright © 2017 Yu-Chen Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Herrington, B. Lacey, P. Sherliker, J. Armitage, and S. Lewington, “Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease,” Circulation Research, vol. 118, no. 4, pp. 535–546, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Barquera, A. Pedroza-Tobías, C. Medina et al., “Global overview of the epidemiology of atherosclerotic cardiovascular disease,” Archives of Medical Research, vol. 46, no. 5, pp. 328–338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Inoue, “Stress and atherosclerotic cardiovascular disease,” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 5, pp. 391–401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Olmez and H. Ozyurt, “Reactive oxygen species and ischemic cerebrovascular disease,” Neurochemistry International, vol. 60, no. 2, pp. 208–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Forstermann, N. Xia, and H. Li, “Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis,” Circulation Research, vol. 120, no. 4, pp. 713–735, 2017. View at Publisher · View at Google Scholar
  6. R. Mia-Jeanne van and E. Pretorius, “Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events,” Current Medicinal Chemistry, vol. 21, no. 19, pp. 2121–2129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Frohlich and A. Al-Sarraf, “Cardiovascular risk and atherosclerosis prevention,” Cardiovascular Pathology, vol. 22, no. 1, pp. 16–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Torres, M. Guevara-Cruz, L. A. Velazquez-Villegas, and A. R. Tovar, “Nutrition and atherosclerosis,” Archives of Medical Research, vol. 46, no. 5, pp. 408–426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Vilahur and L. Badimon, “Antiplatelet properties of natural products,” Vascular Pharmacology, vol. 59, no. 3-4, pp. 67–75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Massaro, E. Scoditti, M. A. Carluccio, and R. De Caterina, “Nutraceuticals and prevention of atherosclerosis: focus on ω-3 polyunsaturated fatty acids and Mediterranean diet polyphenols,” Cardiovascular Therapeutics, vol. 28, no. 4, pp. e13–ee9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Brglez Mojzer, M. Knez Hrncic, M. Skerget, Z. Knez, and U. Bren, “Polyphenols: extraction methods, antioxidative action, bioavailability and anticarcinogenic effects,” Molecules, vol. 21, no. 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Pizzino, N. Irrera, M. Cucinotta et al., “Oxidative stress: harms and benefits for human health,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8416763, 13 pages, 2017. View at Publisher · View at Google Scholar
  13. K. K. Griendling and G. A. FitzGerald, “Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS,” Circulation, vol. 108, no. 16, pp. 1912–1916, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Panth, K. R. Paudel, and K. Parajuli, “Reactive oxygen species: a key hallmark of cardiovascular disease,” Advances in Medicine, vol. 2016, Article ID 9152732, 12 pages, 2016. View at Publisher · View at Google Scholar
  15. S. H. Choi, D. Sviridov, and Y. I. Miller, “Oxidized cholesteryl esters and inflammation,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1862, no. 4, pp. 393–397, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Elahi, Y. X. Kong, and B. M. Matata, “Oxidative stress as a mediator of cardiovascular disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 259–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. W. O'Donnell, D. K. Johnson, L. M. Ziegler, A. J. DiMattina, R. I. Stone, and J. A. Holland, “Endothelial NADPH oxidase: mechanism of activation by low-density lipoprotein,” Endothelium, vol. 10, no. 6, pp. 291–297, 2003. View at Publisher · View at Google Scholar
  18. F. L. Song, R. Y. Gan, Y. Zhang, Q. Xiao, L. Kuang, and H. B. Li, “Total phenolic contents and antioxidant capacities of selected Chinese medicinal plants,” International Journal of Molecular Sciences, vol. 11, no. 6, pp. 2362–2372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Dragland, H. Senoo, K. Wake, K. Holte, and R. Blomhoff, “Several culinary and medicinal herbs are important sources of dietary antioxidants,” The Journal of Nutrition, vol. 133, no. 5, pp. 1286–1290, 2003. View at Google Scholar
  20. Y. Cai, Q. Luo, M. Sun, and H. Corke, “Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer,” Life Sciences, vol. 74, no. 17, pp. 2157–2184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Neveu, J. Perez-Jimenez, F. Vos et al., “Phenol-explorer: an online comprehensive database on polyphenol contents in foods,” Database, vol. 2010, article bap024, 2010. View at Publisher · View at Google Scholar
  22. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, “Polyphenols: food sources and bioavailability,” The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727–747, 2004. View at Google Scholar
  23. K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270–278, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Tsao, “Chemistry and biochemistry of dietary polyphenols,” Nutrients, vol. 2, no. 12, pp. 1231–1246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Williamson and C. Manach, “Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 243S–255S, 2005. View at Google Scholar
  26. S. Ramos, “Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways,” Molecular Nutrition & Food Research, vol. 52, no. 5, pp. 507–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Biesaga, “Influence of extraction methods on stability of flavonoids,” Journal of Chromatography A, vol. 1218, no. 18, pp. 2505–2512, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Scalbert, I. T. Johnson, and M. Saltmarsh, “Polyphenols: antioxidants and beyond,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 215S–217S, 2005. View at Google Scholar
  29. B. Halliwell, J. Rafter, and A. Jenner, “Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?” The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 268s–276s, 2005. View at Google Scholar
  30. J. O. Moskaug, H. Carlsen, M. C. Myhrstad, and R. Blomhoff, “Polyphenols and glutathione synthesis regulation,” The American Journal of Clinical Nutrition, vol. 81, Supplement 1, pp. 277s–283s, 2005. View at Google Scholar
  31. C. C. Chuang and M. K. McIntosh, “Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases,” Annual Review of Nutrition, vol. 31, pp. 155–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Middleton Jr.C. Kandaswami and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar
  33. H. Yoshida, T. Ishikawa, H. Hosoai et al., “Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein,” Biochemical Pharmacology, vol. 58, no. 11, pp. 1695–1703, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. N. R. Perron and J. L. Brumaghim, “A review of the antioxidant mechanisms of polyphenol compounds related to iron binding,” Cell Biochemistry and Biophysics, vol. 53, no. 2, pp. 75–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Bernatova, O. Pechanova, P. Babal, S. Kysela, S. Stvrtina, and R. Andriantsitohaina, “Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 282, no. 3, pp. H942–H948, 2002. View at Publisher · View at Google Scholar
  36. O. Pechanova, I. Bernatova, P. Babal et al., “Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension,” Journal of Hypertension, vol. 22, no. 8, pp. 1551–1559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Fyhrquist, K. Metsarinne, and I. Tikkanen, “Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders,” Journal of Human Hypertension, vol. 9, Supplement 5, pp. S19–S24, 1995. View at Google Scholar
  38. M. Sarr, M. Chataigneau, S. Martins et al., “Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase,” Cardiovascular Research, vol. 71, no. 4, pp. 794–802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. M. Lin, S. W. Hou, B. W. Wang, J. R. Ong, H. Chang, and K. G. Shyu, “Molecular mechanism of (−)-epigallocatechin-3-gallate on balloon injury-induced neointimal formation and leptin expression,” Journal of Agricultural and Food Chemistry, vol. 62, no. 6, pp. 1213–1220, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. El Bekay, M. Álvarez, J. Monteseirín et al., “Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB,” Blood, vol. 102, no. 2, pp. 662–671, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Ried, T. R. Sullivan, P. Fakler, O. R. Frank, and N. P. Stocks, “Effect of cocoa on blood pressure,” The Cochrane Database of Systematic Reviews, no. 8, article Cd008893, 2012. View at Google Scholar
  42. A. Rostami, M. Khalili, N. Haghighat et al., “High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension,” ARYA Atherosclerosis, vol. 11, no. 1, pp. 21–29, 2015. View at Google Scholar
  43. M. M. de Jesus Romero-Prado, J. A. Curiel-Beltran, M. V. Miramontes-Espino, E. G. Cardona-Munoz, A. Rios-Arellano, and L. B. Balam-Salazar, “Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure,” Basic & Clinical Pharmacology & Toxicology, vol. 117, no. 1, pp. 57–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Toledo, F. B. Hu, R. Estruch et al., “Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial,” BMC Medicine, vol. 11, p. 207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Grassi, R. Draijer, C. Schalkwijk et al., “Black tea increases circulating endothelial progenitor cells and improves flow mediated dilatation counteracting deleterious effects from a fat load in hypertensive patients: a randomized controlled study,” Nutrients, vol. 8, no. 11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Grossman, “Does increased oxidative stress cause hypertension?” Diabetes Care, vol. 31, Supplement 2, pp. S185–S189, 2008. View at Publisher · View at Google Scholar
  47. N. C. Ward, J. M. Hodgson, K. D. Croft, V. Burke, L. J. Beilin, and I. B. Puddey, “The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial,” Journal of Hypertension, vol. 23, no. 2, pp. 427–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Grassi, C. Lippi, S. Necozione, G. Desideri, and C. Ferri, “Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons,” The American Journal of Clinical Nutrition, vol. 81, no. 3, pp. 611–614, 2005. View at Google Scholar
  49. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Suganya, E. Bhakkiyalakshmi, D. V. Sarada, and K. M. Ramkumar, “Reversibility of endothelial dysfunction in diabetes: role of polyphenols,” British Journal of Nutrition, vol. 116, no. 2, pp. 223–246, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Lipinski, “Pathophysiology of oxidative stress in diabetes mellitus,” Journal of Diabetes and its Complications, vol. 15, no. 4, pp. 203–210, 2001. View at Publisher · View at Google Scholar
  52. N. Sasaki, T. Yamashita, T. Takaya et al., “Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1068–1076, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Gupta, E. Chough, J. Daley et al., “Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity,” American Journal of Physiology-Cell Physiology, vol. 282, no. 3, pp. C560–C5C6, 2002. View at Publisher · View at Google Scholar
  54. K. Monaghan, J. McNaughten, M. K. McGahon et al., “Hyperglycemia and diabetes downregulate the functional expression of TRPV4 channels in retinal microvascular endothelium,” PLoS One, vol. 10, no. 6, article e0128359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. J. M. Gomes, J. A. Costa, and R. C. Alfenas, “Metabolic endotoxemia and diabetes mellitus: a systematic review,” Metabolism, vol. 68, pp. 133–144, 2017. View at Publisher · View at Google Scholar
  56. F. Le Sage, O. Meilhac, and M. P. Gonthier, “Anti-inflammatory and antioxidant effects of polyphenols extracted from Antirhea borbonica medicinal plant on adipocytes exposed to Porphyromonas gingivalis and Escherichia coli lipopolysaccharides,” Pharmacological Research, vol. 119, pp. 303–312, 2017. View at Publisher · View at Google Scholar
  57. L. P. Aiello and J. S. Wong, “Role of vascular endothelial growth factor in diabetic vascular complications,” Kidney International, vol. 58, Supplement 77, pp. S113–S119, 2000. View at Publisher · View at Google Scholar
  58. T. Mrudula, P. Suryanarayana, P. N. Srinivas, and G. B. Reddy, “Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina,” Biochemical and Biophysical Research Communications, vol. 361, no. 2, pp. 528–532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Sawatpanich, H. Petpiboolthai, B. Punyarachun, and V. Anupunpisit, “Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin,” Journal of the Medical Association of Thailand, vol. 93, Supplement 2, pp. S1–S8, 2010. View at Google Scholar
  60. J. Y. Shin, J. Sohn, and K. H. Park, “Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model,” Journal of Korean Medical Science, vol. 28, no. 4, pp. 608–613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. A. W. Zieske, G. T. Malcom, and J. P. Strong, “Natural history and risk factors of atherosclerosis in children and youth: the PDAY study,” Pediatric Pathology & Molecular Medicine, vol. 21, no. 2, pp. 213–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. M. L. Kortelainen and T. Sarkioja, “Visceral fat and coronary pathology in male adolescents,” International Journal of Obesity, vol. 25, no. 2, pp. 228–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Hulsmans and P. Holvoet, “The vicious circle between oxidative stress and inflammation in atherosclerosis,” Journal of Cellular and Molecular Medicine, vol. 14, no. 1-2, pp. 70–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. K. Lin and S. Y. Lin-Shiau, “Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols,” Molecular Nutrition & Food Research, vol. 50, no. 2, pp. 211–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Daval, F. Diot-Dupuy, R. Bazin et al., “Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 25250–25257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. C. L. Lin, H. C. Huang, and J. K. Lin, “Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells,” Journal of Lipid Research, vol. 48, no. 11, pp. 2334–2343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. H.-J. Ko, C.-Y. Lo, B.-J. Wang, R. Y.-Y. Chiou, and S.-M. Lin, “Theaflavin-3,3-digallate, a black tea polyphenol, stimulates lipolysis associated with the induction of mitochondrial uncoupling proteins and AMPK–FoxO3A–MnSOD pathway in 3T3-L1 adipocytes,” Journal of Functional Foods, vol. 17, pp. 271–282, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Shishikura, S. Khokhar, and B. S. Murray, “Effects of tea polyphenols on emulsification of olive oil in a small intestine model system,” Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1906–1913, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. M. A. Vermeer, T. P. Mulder, and H. O. Molhuizen, “Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles,” Journal of Agricultural and Food Chemistry, vol. 56, no. 24, pp. 12031–12036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Uchiyama, Y. Taniguchi, A. Saka, A. Yoshida, and H. Yajima, “Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo,” Nutrition, vol. 27, no. 3, pp. 287–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Ashigai, Y. Taniguchi, M. Suzuki et al., “Fecal lipid excretion after consumption of a black tea polyphenol containing beverage-randomized, placebo-controlled, double-blind, crossover study,” Biological & Pharmaceutical Bulletin, vol. 39, no. 5, pp. 699–704, 2016. View at Publisher · View at Google Scholar
  72. T. F. Hsu, A. Kusumoto, K. Abe et al., “Polyphenol-enriched oolong tea increases fecal lipid excretion,” European Journal of Clinical Nutrition, vol. 60, no. 11, pp. 1330–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Hosoyamada and M. Yamada, “Effects of dietary fish oil and apple polyphenol on the concentration serum lipids and excretion of fecal bile acids in rats,” Journal of Nutritional Science and Vitaminology, vol. 63, no. 1, pp. 21–27, 2017. View at Publisher · View at Google Scholar
  74. “Obesity and overweight: WHO fact sheet,” 2016, http://who.int/mediacentre/factsheets/fs311/en/.
  75. J. M. Genkinger, C. M. Kitahara, L. Bernstein et al., “Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies,” Annals of Oncology, vol. 26, no. 11, pp. 2257–2266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. R. H. Eckel and R. M. Krauss, “American Heart Association call to action: obesity as a major risk factor for coronary heart disease,” Circulation, vol. 97, no. 21, pp. 2099-2100, 1998. View at Publisher · View at Google Scholar
  77. P. Poirier, T. D. Giles, G. A. Bray et al., “Obesity and cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 968–976, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. H. K. Vincent and A. G. Taylor, “Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans,” International Journal of Obesity, vol. 30, no. 3, pp. 400–418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Pan, Y. Gao, and Y. Tu, “Mechanisms of body weight reduction by black tea polyphenols,” Molecules, vol. 21, no. 12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  80. B. L. Wajchenberg, “Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome,” Endocrine Reviews, vol. 21, no. 6, pp. 697–738, 2000. View at Publisher · View at Google Scholar
  81. S. de Ferranti and D. Mozaffarian, “The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences,” Clinical Chemistry, vol. 54, no. 6, pp. 945–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. B. B. Kahn and J. S. Flier, “Obesity and insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 473–481, 2000. View at Publisher · View at Google Scholar
  83. C. L. Shen, J. J. Cao, R. Y. Dagda et al., “Green tea polyphenols benefits body composition and improves bone quality in long-term high-fat diet-induced obese rats,” Nutrition Research, vol. 32, no. 6, pp. 448–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. H. W. Chen, M. L. Chien, Y. H. Chaung, C. K. Lii, and T. S. Wang, “Extracts from cigarette smoke induce DNA damage and cell adhesion molecule expression through different pathways,” Chemico-Biological Interactions, vol. 150, no. 3, pp. 233–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Hossain, T. Sathe, V. Fazio et al., “Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier,” Brain Research, vol. 1287, pp. 192–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Naik, N. Fofaria, S. Prasad et al., “Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?” BMC Neuroscience, vol. 15, p. 51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Sobczak, D. Golka, and I. Szoltysek-Boldys, “The effects of tobacco smoke on plasma alpha- and gamma-tocopherol levels in passive and active cigarette smokers,” Toxicology Letters, vol. 151, no. 3, pp. 429–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Dietrich, G. Block, E. P. Norkus et al., “Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase γ-tocopherol in vivo after adjustment for dietary antioxidant intakes,” The American Journal of Clinical Nutrition, vol. 77, no. 1, pp. 160–166, 2003. View at Google Scholar
  89. B. Isik, A. Ceylan, and R. Isik, “Oxidative stress in smokers and non-smokers,” Inhalation Toxicology, vol. 19, no. 9, pp. 767–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Masubuchi, S. Koyama, E. Sato et al., “Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity,” The American Journal of Pathology, vol. 153, no. 6, pp. 1903–1912, 1998. View at Publisher · View at Google Scholar
  91. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, “Evaluation of oxidative stress in patients with acute ischemic stroke,” Romanian journal of internal medicine = Revue roumaine de medecine interne, vol. 51, no. 2, pp. 97–106, 2013. View at Google Scholar
  92. T. Mannami, H. Iso, S. Baba et al., “Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC study cohort I,” Stroke, vol. 35, no. 6, pp. 1248–1253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. J. S. Gill, M. J. Shipley, S. A. Tsementzis et al., “Cigarette smoking. A risk factor for hemorrhagic and nonhemorrhagic stroke,” Archives of Internal Medicine, vol. 149, no. 9, pp. 2053–2057, 1989. View at Publisher · View at Google Scholar
  94. M. Hossain, P. Mazzone, W. Tierney, and L. Cucullo, “In vitro assessment of tobacco smoke toxicity at the BBB: do antioxidant supplements have a protective role?” BMC Neuroscience, vol. 12, p. 92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Prasad, R. K. Sajja, M. A. Kaisar et al., “Role of Nrf2 and protective effects of metformin against tobacco smoke-induced cerebrovascular toxicity,” Redox Biology, vol. 12, pp. 58–69, 2017. View at Publisher · View at Google Scholar
  96. J. K. Willcox, S. L. Ash, and G. L. Catignani, “Antioxidants and prevention of chronic disease,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 4, pp. 275–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Del Bo, M. Porrini, D. Fracassetti, J. Campolo, D. Klimis-Zacas, and P. Riso, “A single serving of blueberry (V. corymbosum) modulates peripheral arterial dysfunction induced by acute cigarette smoking in young volunteers: a randomized-controlled trial,” Food & Function, vol. 5, no. 12, pp. 3107–3116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Sticozzi, F. Cervellati, X. M. Muresan, C. Cervellati, and G. Valacchi, “Resveratrol prevents cigarette smoke-induced keratinocytes damage,” Food & Function, vol. 5, no. 9, pp. 2348–2356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. M. J. Bao, J. Shen, Y. L. Jia et al., “Apple polyphenol protects against cigarette smoke-induced acute lung injury,” Nutrition, vol. 29, no. 1, pp. 235–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., “A protein kinase involved in the regulation of inflammatory cytokine biosynthesis,” Nature, vol. 372, no. 6508, pp. 739–746, 1994. View at Publisher · View at Google Scholar
  101. C. Qing, P. Chen, and X. Xiang, “Effect of tea polyphenols on oxidative damage and apoptosis in human bronchial epithelial cells induced by low-dose cigarette smoke condensate,” Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences, vol. 35, no. 2, pp. 123–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. W. C. Aird, “Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. H. Lum and K. A. Roebuck, “Oxidant stress and endothelial cell dysfunction,” American Journal of physiology Cell physiology, vol. 280, no. 4, pp. C719–C741, 2001. View at Google Scholar
  104. S. M. Davidson and M. R. Duchen, “Endothelial mitochondria: contributing to vascular function and disease,” Circulation Research, vol. 100, no. 8, pp. 1128–1141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. A. J. Flammer, T. Anderson, D. S. Celermajer et al., “The assessment of endothelial function: from research into clinical practice,” Circulation, vol. 126, no. 6, pp. 753–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. H. A. Hadi, C. S. Carr, and J. Al Suwaidi, “Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome,” Vascular Health and Risk Management, vol. 1, no. 3, pp. 183–198, 2005. View at Google Scholar
  107. C. E. Storniolo, J. Rosello-Catafau, X. Pinto, M. T. Mitjavila, and J. J. Moreno, “Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1,” Redox Biology, vol. 2, pp. 971–977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. M. B. Engler, M. M. Engler, C. Y. Chen et al., “Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults,” Journal of the American College of Nutrition, vol. 23, no. 3, pp. 197–204, 2004. View at Publisher · View at Google Scholar
  109. D. F. Fitzpatrick, S. L. Hirschfield, T. Ricci, P. Jantzen, and R. G. Coffey, “Endothelium-dependent vasorelaxation caused by various plant extracts,” Journal of Cardiovascular Pharmacology, vol. 26, no. 1, pp. 90–95, 1995. View at Publisher · View at Google Scholar
  110. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum, “Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity,” New England Journal of Medicine, vol. 320, no. 14, pp. 915–924, 1989. View at Publisher · View at Google Scholar
  111. D. Steinberg, “The LDL modification hypothesis of atherogenesis: an update,” Journal of Lipid Research, vol. 50, pp. S376–SS81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Steinberg and J. L. Witztum, “Oxidized low-density lipoprotein and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 12, pp. 2311–2316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. N. Santanam and S. Parthasarathy, “Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases,” Journal of Clinical Investigation, vol. 95, no. 6, pp. 2594–2600, 1995. View at Publisher · View at Google Scholar
  114. G. Maiolino, G. Rossitto, P. Caielli, V. Bisogni, G. P. Rossi, and L. A. Calo, “The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts,” Mediators of Inflammation, vol. 2013, Article ID 714653, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. B. Simini, “Serge Renaud: from French paradox to Cretan miracle,” The Lancet, vol. 355, no. 9197, p. 48, 2000. View at Publisher · View at Google Scholar
  116. E. N. Frankel, J. Kanner, J. B. German, E. Parks, and J. E. Kinsella, “Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine,” The Lancet, vol. 341, no. 8843, pp. 454–457, 1993. View at Publisher · View at Google Scholar · View at Scopus
  117. J. H. Chen, M. S. Lee, C. P. Wang, C. C. Hsu, and H. H. Lin, “Autophagic effects of Hibiscus sabdariffa leaf polyphenols and epicatechin gallate (ECG) against oxidized LDL-induced injury of human endothelial cells,” European Journal of Nutrition, vol. 56, no. 5, pp. 1963–1981, 2017. View at Publisher · View at Google Scholar · View at Scopus
  118. N. Suzuki-Sugihara, Y. Kishimoto, E. Saita et al., “Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans,” Nutrition Research, vol. 36, no. 1, pp. 16–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Knall, G. S. Worthen, and G. L. Johnson, “Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3052–7, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Imai and D. R. Clemmons, “Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I,” Endocrinology, vol. 140, no. 9, pp. 4228–4235, 1999. View at Publisher · View at Google Scholar
  121. J. C. Hedges, M. A. Dechert, I. A. Yamboliev et al., “A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration,” Journal of Biological Chemistry, vol. 274, no. 34, pp. 24211–24219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Rosenkranz, D. Knirel, H. Dietrich, M. Flesch, E. Erdmann, and M. Bohm, “Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the “French paradox”,” The FASEB Journal, vol. 16, no. 14, pp. 1958–1960, 2002. View at Publisher · View at Google Scholar
  123. M. Dell'Agli, A. Busciala, and E. Bosisio, “Vascular effects of wine polyphenols,” Cardiovascular Research, vol. 63, no. 4, pp. 593–602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  124. H. C. Lin, M. J. Hsieh, C. H. Peng, S. F. Yang, and C. N. Huang, “Pterostilbene inhibits vascular smooth muscle cells migration and matrix metalloproteinase-2 through modulation of MAPK pathway,” Journal of Food Science, vol. 80, no. 10, pp. H2331–H2335, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Wicinski, B. Malinowski, M. M. Weclewicz, E. Grzesk, and G. Grzesk, “Resveratrol increases serum BDNF concentrations and reduces vascular smooth muscle cells contractility via a NOS-3-independent mechanism,” BioMed Research International, vol. 2017, Article ID 9202954, 7 pages, 2017. View at Publisher · View at Google Scholar
  126. H. Y. Li, M. Yang, Z. Li, and Z. Meng, “Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress,” International Journal of Molecular Medicine, vol. 39, no. 5, pp. 1307–1316, 2017. View at Publisher · View at Google Scholar
  127. K. Shimada, “Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis,” Circulation Journal, vol. 73, no. 6, pp. 994–1001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. K. J. Moore and I. Tabas, “Macrophages in the pathogenesis of atherosclerosis,” Cell, vol. 145, no. 3, pp. 341–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. O. Rom, H. Korach-Rechtman, T. Hayek et al., “Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice,” Archives of Toxicology, vol. 91, no. 4, pp. 1709–1725, 2017. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Sarkar, A. A. Siddiqui, S. Mazumder et al., “Ellagic acid, a dietary polyphenol, inhibits tautomerase activity of human macrophage migration inhibitory factor and its pro-inflammatory responses in human peripheral blood mononuclear cells,” Journal of Agricultural and Food Chemistry, vol. 63, no. 20, pp. 4988–4998, 2015. View at Publisher · View at Google Scholar · View at Scopus
  131. E. Scoditti, A. Nestola, M. Massaro et al., “Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCα and PKCβ1 inhibition,” Atherosclerosis, vol. 232, no. 1, pp. 17–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. L. N. Broekhuizen, D. F. van Wijk, H. Vink et al., “Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors,” British Journal of Nutrition, vol. 106, no. 9, pp. 1416–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  133. C. T. Ford, S. Richardson, F. McArdle et al., “Identification of (poly)phenol treatments that modulate the release of pro-inflammatory cytokines by human lymphocytes,” British Journal of Nutrition, vol. 115, no. 10, pp. 1699–1710, 2016. View at Publisher · View at Google Scholar · View at Scopus
  134. C. Faggio, A. Sureda, S. Morabito et al., “Flavonoids and platelet aggregation: a brief review,” European Journal of Pharmacology, vol. 807, pp. 91–101, 2017. View at Publisher · View at Google Scholar
  135. G. E. Hirsch, P. R. Viecili, A. S. de Almeida et al., “Natural products with antiplatelet action,” Current Pharmaceutical Design, vol. 23, no. 8, pp. 1228–1246, 2017. View at Publisher · View at Google Scholar
  136. T. Mattiello, E. Trifiro, G. S. Jotti, and F. M. Pulcinelli, “Effects of pomegranate juice and extract polyphenols on platelet function,” Journal of Medicinal Food, vol. 12, no. 2, pp. 334–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. D. A. Pearson, T. G. Paglieroni, D. Rein et al., “The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function,” Thrombosis Research, vol. 106, no. 4-5, pp. 191–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. D. Rein, T. G. Paglieroni, T. Wun et al., “Cocoa inhibits platelet activation and function,” The American Journal of Clinical Nutrition, vol. 72, no. 1, pp. 30–35, 2000. View at Google Scholar
  139. R. R. Holt, D. D. Schramm, C. L. Keen, S. A. Lazarus, and H. H. Schmitz, “Chocolate consumption and platelet function,” JAMA, vol. 287, no. 17, pp. 2212-2213, 2002. View at Publisher · View at Google Scholar
  140. G. Rull, Z. N. Mohd-Zain, J. Shiel et al., “Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation,” Vascular Pharmacology, vol. 71, pp. 70–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  141. R. Carnevale, L. Loffredo, P. Pignatelli et al., “Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers,” Journal of Thrombosis and Haemostasis, vol. 10, no. 1, pp. 125–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. E. Saita, K. Kondo, and Y. Momiyama, “Anti-inflammatory diet for atherosclerosis and coronary artery disease: antioxidant foods,” Clinical Medicine Insights Cardiology, vol. 8, Supplement 3, pp. 61–65, 2015. View at Publisher · View at Google Scholar · View at Scopus
  143. Y. Kokubo, H. Iso, J. Ishihara, K. Okada, M. Inoue, and S. Tsugane, “Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan public health center-based (JPHC) study cohort I,” Circulation, vol. 116, no. 22, pp. 2553–2562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  144. H. N. Hodis, W. J. Mack, N. Kono et al., “Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial,” Stroke, vol. 42, no. 11, pp. 3168–3175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. D. Pala, P. O. Barbosa, C. T. Silva et al., “Acai (Euterpe oleracea Mart.) dietary intake affects plasma lipids, apolipoproteins, cholesteryl ester transfer to high-density lipoprotein and redox metabolism: a prospective study in women,” Clinical Nutrition, 2017. View at Publisher · View at Google Scholar
  146. T. Namekata, K. Suzuki, N. Ishizuka, and K. Shirai, “Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study,” BMC Cardiovascular Disorders, vol. 11, no. 1, p. 51, 2011. View at Google Scholar
  147. H. Imamura, T. Yamaguchi, D. Nagayama, A. Saiki, K. Shirai, and I. Tatsuno, “Resveratrol ameliorates arterial stiffness assessed by cardio-ankle vascular index in patients with type 2 diabetes mellitus,” International Heart Journal, vol. 58, no. 4, pp. 577–583, 2017. View at Publisher · View at Google Scholar
  148. C. Pasten, N. C. Olave, L. Zhou, E. M. Tabengwa, P. E. Wolkowicz, and H. E. Grenett, “Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: molecular contributor to cardiovascular protection,” Thrombosis Research, vol. 121, no. 1, pp. 59–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. A. Sinkovic, D. Suran, L. Lokar et al., “Rosemary extracts improve flow-mediated dilatation of the brachial artery and plasma PAI-1 activity in healthy young volunteers,” Phytotherapy Research, vol. 25, no. 3, pp. 402–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. J. Lekakis, L. S. Rallidis, I. Andreadou et al., “Polyphenols compounds from red grapes acutely improve endothelial function in patients with coronary heart disease,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 12, no. 6, pp. 596–600, 2005. View at Publisher · View at Google Scholar
  151. K. Magyar, R. Halmosi, A. Palfi et al., “Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease,” Clinical Hemorheology and Microcirculation, vol. 50, no. 3, pp. 179–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  152. M. G. Hertog, E. J. Feskens, P. C. Hollman, M. B. Katan, and D. Kromhout, “Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study,” The Lancet, vol. 342, no. 8878, pp. 1007–1011, 1993. View at Publisher · View at Google Scholar · View at Scopus
  153. P. Knekt, R. Jarvinen, A. Reunanen, and J. Maatela, “Flavonoid intake and coronary mortality in Finland: a cohort study,” BMJ, vol. 312, no. 7029, pp. 478–481, 1996. View at Publisher · View at Google Scholar
  154. P. J. Mink, C. G. Scrafford, L. M. Barraj et al., “Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women,” The American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 895–909, 2007. View at Google Scholar
  155. S. R. Hsieh, W. C. Cheng, Y. M. Su, C. H. Chiu, and Y. M. Liou, “Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury,” BioMedicine, vol. 4, p. 23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  156. H. T. Lai, D. E. Threapleton, A. J. Day, G. Williamson, J. E. Cade, and V. J. Burley, “Fruit intake and cardiovascular disease mortality in the UK Women’s cohort study,” European Journal of Epidemiology, vol. 30, no. 9, pp. 1035–1048, 2015. View at Publisher · View at Google Scholar · View at Scopus
  157. M. A. Martinez-Gonzalez, J. Salas-Salvado, R. Estruch, D. Corella, M. Fito, and E. Ros, “Benefits of the Mediterranean diet: insights from the PREDIMED study,” Progress in Cardiovascular Diseases, vol. 58, no. 1, pp. 50–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  158. “The top 10 causes of death: WHO, fact sheet,” 2017, http://who.int/mediacentre/factsheets/fs310/en/.
  159. S. M. A. A. Evers, J. N. Struijs, A. J. H. A. Ament, M. L. L. van Genugten, J. C. Jager, and G. A. M. van den Bos, “International comparison of stroke cost studies,” Stroke, vol. 35, no. 5, pp. 1209–1215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. D. Wan, Y. Zhou, K. Wang, Y. Hou, R. Hou, and X. Ye, “Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats,” Brain Research Bulletin, vol. 121, pp. 255–262, 2016. View at Publisher · View at Google Scholar · View at Scopus
  161. V. Carito, M. Ceccanti, L. Tarani, G. Ferraguti, G. N. Chaldakov, and M. Fiore, “Neurotrophins’ modulation by olive polyphenols,” Current Medicinal Chemistry, vol. 23, no. 28, pp. 3189–3197, 2016. View at Publisher · View at Google Scholar
  162. I. L. Hung, Y. C. Hung, L. Y. Wang et al., “Chinese herbal products for ischemic stroke,” The American Journal of Chinese Medicine, vol. 43, no. 7, pp. 1365–1379, 2015. View at Publisher · View at Google Scholar · View at Scopus
  163. Z. M. Wang, D. Zhao, Z. L. Nie et al., “Flavonol intake and stroke risk: a meta-analysis of cohort studies,” Nutrition, vol. 30, no. 5, pp. 518–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  164. M. E. Goetz, S. E. Judd, T. J. Hartman, W. McClellan, A. Anderson, and V. Vaccarino, “Flavanone intake is inversely associated with risk of incident ischemic stroke in the REasons for geographic and racial differences in stroke (REGARDS) study,” Journal of Nutrition, vol. 146, no. 11, pp. 2233–2243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  165. C. C. Chang, Y. C. Chang, W. L. Hu, and Y. C. Hung, “Oxidative stress and Salvia miltiorrhiza in aging-associated cardiovascular diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4797102, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus